ReviewJournal of clinical medicine2021

PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis.

Margarita Majem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.